FIELD: medicine.
SUBSTANCE: blood serum MCP-1 and G-CSF cytokine concentrations are measured. If the MCP-1 concentration is more than 218 pg/ml, and the G-CSF concentration is more than 24 pg/ml, the frequently recurrent clinical course of chronic pancreatitis is predicted.
EFFECT: method enables the early accurate prediction of the frequently recurrent clinical course of the disease.
1 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR FORECASTING THE PROGRESS OF CHRONIC PANCREATITIS | 1991 |
|
RU2008685C1 |
| METHOD FOR DIAGNOSING THE CASES OF CHRONIC PANCREATITIS | 2001 |
|
RU2199748C2 |
| METHOD FOR PREDICTING COURSE OF ISOLATED FORM OF ACANTHOLYTIC PERVASIVE CAVITY | 2018 |
|
RU2688209C1 |
| METHOD FOR PREDICTING THE TRANSITION OF MODERATELY SEVERE NUMMULAR MICROBIAL ECZEMA TO SEVERE ONE | 2018 |
|
RU2681656C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF ECZEMA IN PATIENTS SUFFERING ACCOMPANIED CHRONIC GASTRODUODENITIS | 2011 |
|
RU2461836C1 |
| METHOD FOR PREDICTING THE LETHAL OUTCOME IN PATIENTS WITH SEVERE CoVID-19 | 2021 |
|
RU2780748C1 |
| METHOD OF PREDICTING DEVELOPMENT OF PERSISTENT RECURRENT PANCREATITIS | 1997 |
|
RU2123703C1 |
| METHOD FOR PREDICTING RECRUDESCENCE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN PATIENTS WITH INSOMNIA | 2018 |
|
RU2681272C1 |
| METHOD OF PREDICTING PROGRESSION OF HIV INFECTION IN PATIENTS RECEIVING ANTIRETROVIRAL THERAPY | 2019 |
|
RU2697392C1 |
| METHOD FOR PREDICTING DEVELOPMENT OF OTITIS MEDIA IN PATIENTS WITH RHINOSINUSITIS | 2020 |
|
RU2750024C1 |
